Citius Pharmaceuticals (NASDAQ: CTXR) Advances Oncology Asset, Paving Way For Spin Out Of Advanced T-cell Lymphoma Treatment
–News Direct– By Meg Flippin, Benzinga Chemotherapy and radiation are proven ways to treat cancer, but for the patients, they